Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax

11 Jan 2009

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Malaria Research and Control
Share to Mosquito-borne diseases and control

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19138714
DOI: 10.1016/j.vaccine.2008.12.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivaxPMID 19138714Read ↗

Emerging Technologies for Low‐Cost, Rapid Vaccine ManufactureSemantic proximity Read ↗

Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discoverySemantic proximity Read ↗

Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccineSemantic proximity Read ↗

Advances and challenges in malaria vaccine developmentSemantic proximity Read ↗

Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisationSemantic proximity Read ↗

Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)Semantic proximity Read ↗

Escherichia coli as a glycoprotein production host: recent developments and challengesSemantic proximity Read ↗

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectorsSemantic proximity Read ↗

Stage-specific processing of Pfs230, a Plasmodium falciparum transmission-blocking vaccine candidateSemantic proximity Read ↗

Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic moleculesSemantic proximity Read ↗

Genetic engineering of attenuated malaria parasites for vaccinationSemantic proximity Read ↗

Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparumSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.